Asmerom Amine sold $250K of CHYM

Asmerom Amine (Chief Accounting Officer) sold 10,000 shares of Chime Financial, Inc. (CHYM) at $25.00 ($0.25M total) on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Asmerom Amine
Published Aug 5, 2026, 11:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 11:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CHYM
Neutral
high confidence
Mentioned
$CHYM
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CHYMNeutralLow
01

Why it matters

The newest fact is the specific open-market sale size, price, and execution date, with confirmation that it was under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale, but the 10b5-1 framing and lack of fundamental updates make it low-impact.

03

What to watch

The article does not state whether other insiders sold/bought around the same window, nor does it provide context on total insider holdings beyond the post-transaction figure.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-05 after-hours; reflects sale executed 2026-08-04

Background

The article is a SEC Form 4 insider transaction disclosure for Chime Financial, Inc. (CHYM).

Company-level read

Ticker impact

$CHYMNeutralHigh confidence
Context

Chime Financial insider Asmerom Amine sold 10,000 shares at $25.00 on 2026-08-04 under a pre-arranged 10b5-1 plan, per Form 4.

Expected impact

Low likelihood of a sustained price move solely from this disclosure; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan, and the article contains no accompanying operational or guidance change.

Market effects

No direct sector read-through; this is an issuer-specific insider transaction.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Chime Financial, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Asmerom Amine

    Chief Accounting Officer who sold shares.

  • 10b5-1 plan

    Pre-arranged plan that reduces interpretive weight of the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CHYMHigh

Why is Chime Financial stock climbing today?

Chime Financial (CHYM) stock rose 2.8% in pre-market trading ahead of its inclusion in the S&P MidCap 400 index. Analysts raised price targets, with an average recommendation of 'Buy'. Q3 revenue grew 32% to $718M, and guidance was increased. The stock's gain contrasts with broader market declines.

$CHYMMed

Wells Fargo raises Chime Financial price target on strong results

Wells Fargo raised its price target for Chime Financial (CHYM) to $42.00 from $39.00, citing strong Q3 results and improved 2026 guidance. The company's revenue grew 26% with an 89% gross profit margin, though it remains unprofitable with an EPS of -$0.05. Chime's stock has gained 56% over the past year, trading at $29.87 with a market cap of $11.31 billion. The firm expects the Stride acquisition to close in early 2027, generating $100 million in annual synergies.

$CHYMHighAI 8/10

B.Riley raises Chime Financial stock price target on strong results

B.Riley raised its price target on Chime Financial (NASDAQ:CHYM) to $45.00, citing strong Q3 2026 results. Revenue was $718M, adjusted EBITDA $137M, both exceeding estimates. The company reported GAAP profitability for the third straight quarter, with net income of $44M. Active members reached 10.9M, and management raised full-year guidance. CHYM stock is up 56% over the past year, trading at $29.87.